Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy

Clinical Cancer Research

Volumn 6, Issue 4, 2000, Pages 1415-1421

  Samimi, Goli ^a   Fink, Daniel ^c   Varki, Nissi M ^b   Husain, Amreen ^d   Hoskins, William J ^d   Alberts, David S ^e   Howell, Stephen B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; M PROTEIN; PROTEIN MLH1; PROTEIN MSH2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; CA-125 ANTIGEN; CARBOPLATIN; CARRIER PROTEINS; CISPLATIN; DATA INTERPRETATION, STATISTICAL; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS;

EID: 0034088090     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Fink, D., Aebi, S., and Howell, S. B. The role of DNA mismatch repair in drug resistance. Clin. Cancer Res., 4: 1-5, 1998.
2. Anthoney, D. A., Mcllwrath, A. J., Gallagher, W. M., Edlin, A. R. M., and Brown, R. Microsatellite instability, apoptosis and loss of p53 function in drug resistant tumor cells. Cancer Res., 56: 1374-1381, 1996.
3. Fink, D., Nebel, S., Aebi, S., Nehme, A., and Howell, S. B. Loss of DNA mismatch repair due to knockout of MSH2 or PMS2 results in resistance to cisplatin and carboplatin. Intl. J. Oncol., 11: 539-542, 1997.
4. Aebi, S., Kurdi-Haidar, B., Gordon, R., Cenni, B., Zheng, H., Fink, D., Christen, R., Boland, C. R., Koi, M., Fishel, R., and Howell, S. B. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res., 56: 3087-3090, 1996.
5. Brown, R., Hirst, G., Gallagher, W. M., Mcllwrath, A. J., Van der Zee, A., and Anthoney, D. A. hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents. Oncogene, 15: 45-52, 1997.
6. Fink, D., Nebel, S., Norris, P. S., Baergen, R. N., Wilczynski, S. P., Costa, M. J., Haas, M., Cannistra, S. A., and Howell, S. B. Enrichment of DNA mismatch repair-deficient cells during treatment with cisplatin. Intl. J. Cancer, 77: 741-746, 1998.
7. Hanford, M. G., Rushton, B. C., Gowen, L. C., and Farber, R. A. Microsatellite mutation rates in cancer cell lines deficient or proficient in mismatch repair. Oncogene, 16: 2389-2393, 1998.
8. Muggia, F. M., Liu, P. Y., Alberts, D. S., Wallace, D. L., O'Toole, R. V., Terada, K. Y., Franklin, E. W., Harrer, G. W., Goldberg, D. A., and Hannigan, E. V. Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy - a randomized Phase II study by the Southwest Oncology Group. Gynecol. Oncol., 61: 395-402, 1996.
9. Mackean, M. J., Millan, D., Paul, J., Kaye, S. B., and Brown, R. The clinical relevance of mismatch repair protein immunohistochemistry in ovarian cancer. Proc. Am. Assoc. Cancer Res., 40: 498, 1999.
10. Strathdee, G., Mackean, M. J., Illand, M., and Brown, R. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene, 18: 2335-2341, 1999.
11. Hempling, R. E., Piver, M. S., Natarajan, N., Baker, T. R., Thompson, J. M., Hicks, M. L., and Mettlin, C. Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancer. J. Surg. Oncol., 54: 34-44, 1999.
12. King, B. L., Carcangiu, M. L., Carter, D., Kiechle, M., Pfisterer, J., Pfleiderer, A., and Kacinski, B. M. Microsatellite instability in ovarian neoplasms. Brit. J. Cancer, 72: 376-382, 1995.